Evidence map›Paper›PMID 31906275›Full record

ArticleCancers2020

Protein Oxidative Damage in UV-Related Skin Cancer and Dysplastic Lesions Contributes to Neoplastic Promotion and Progression.

Antonella Tramutola, Susanna Falcucci, Umberto Brocco, Francesca Triani, Chiara Lanzillotta, Michele Donati, Chiara Panetta, Fabiola Luzi, Federica Iavarone, Federica Vincenzoni and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05152407 (MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05152407 naunknown statusnot on this mapstarted 2022, after this paper: background citation

MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis A Single-center Clinical Study in Two Phases: First Phase: Randomized Double-blind Clinical Interventional Study Versus Placebo in Split Face or Split Skull Second Phase: Open-label Observational Clinical Study on the Entire Face or Skull

TypeinterventionalSponsorNAOS Institute of Life ScienceRan2022 to 2023Enrolled35ConditionsActinic Keratosis, Actinic LentigoArmsTopical application of MRB 0.3% serum and placebo serum (hemi face or skull)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. The Oxidative Stress: Origin and Role in Aging and Diseases.Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Inhibitory effect of kaempferol on mouse melanoma cell line B16Postepy dermatologii i alergologii · 2021
    Article
  9. ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities.Oxidative medicine and cellular longevity · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Antonella TramutolaDepartment of Biochemical Sciences, Sapienza Rome University, P. le Aldo Moro 5, 00185 Rome, Italy.
Susanna FalcucciDepartment of RiDAIT, the Regina Elena National Cancer Institute IRCCS, via Elio Chianesi 53, 00144 Rome, Italy.
Umberto BroccoDepartment of RiDAIT, the Regina Elena National Cancer Institute IRCCS, via Elio Chianesi 53, 00144 Rome, Italy.
Francesca TrianiDepartment of Biochemical Sciences, Sapienza Rome University, P. le Aldo Moro 5, 00185 Rome, Italy.
Chiara LanzillottaDepartment of Biochemical Sciences, Sapienza Rome University, P. le Aldo Moro 5, 00185 Rome, Italy.
Michele DonatiDepartment of Pathology, University Campus Biomedico, via Alvaro del Portillo 21, 00128 Rome, Italy.
Chiara PanettaUOSD Dermopathology, the San Gallicano National Dermatological Institute IRCCS, via Elio Chianesi 53, 00144 Rome, Italy.
Fabiola LuziUOSD Dermatological and Reconstructive Plastic Surgery, the San Gallicano National Dermatological Institute IRCCS, via Elio Chianesi 53, 00144 Rome, Italy.
Federica IavaroneIstituto di Biochimica e Biochimica Clinica, Università̀ Cattolica, Dip. di Diagnostica di Laboratorio e Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
Federica VincenzoniIstituto di Biochimica e Biochimica Clinica, Università̀ Cattolica, Dip. di Diagnostica di Laboratorio e Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
Massimo CastagnolaIstituto di Biochimica e Biochimica Clinica, Università̀ Cattolica, Dip. di Diagnostica di Laboratorio e Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
Marzia PerluigiDepartment of Biochemical Sciences, Sapienza Rome University, P. le Aldo Moro 5, 00185 Rome, Italy.
Fabio Di DomenicoDepartment of Biochemical Sciences, Sapienza Rome University, P. le Aldo Moro 5, 00185 Rome, Italy.
Federico De MarcoDepartment of RiDAIT, the Regina Elena National Cancer Institute IRCCS, via Elio Chianesi 53, 00144 Rome, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITSapienza University of Rome · ITSan Gallicano Hospital · ITUniversità Campus Bio-Medico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ultraviolet (UV) component of solar radiation is the major driving force of skin carcinogenesis. Most of studies on UV carcinogenesis actually focus on DNA damage while their proteome-damaging ability and its contribution to skin carcinogenesis have remained largely underexplored. A redox proteomic analysis of oxidized proteins in solar-induced neoplastic skin lesion and perilesional areas has been conducted showing that the protein oxidative burden mostly concerns a selected number of proteins participating to a defined set of functions, namely: chaperoning and stress response; protein folding/refolding and protein quality control; proteasomal function; DNA damage repair; protein- and vesicle-trafficking; cell architecture, adhesion/extra-cellular matrix (ECM) interaction; proliferation/oncosuppression; apoptosis/survival, all of them ultimately concurring either to structural damage repair or to damage detoxication and stress response. In peri-neoplastic areas the oxidative alterations are conducive to the persistence of genetic alterations, dysfunctional apoptosis surveillance, and a disrupted extracellular environment, thus creating the condition for transformant clones to establish, expand and progress. A comparatively lower burden of oxidative damage is observed in neoplastic areas. Such a finding can reflect an adaptive selection of best fitting clones to the sharply pro-oxidant neoplastic environment. In this context the DNA damage response appears severely perturbed, thus sustaining an increased genomic instability and an accelerated rate of neoplastic evolution. In conclusion UV radiation, in addition to being a cancer-initiating agent, can act, through protein oxidation, as a cancer-promoting agent and as an inducer of genomic instability concurring with the neoplastic progression of established lesions.

Indexed as

cancer promotioncarcinogenesisprotein damageprotein oxidationredox proteomicsskin cancersolar radiationstress response.ultraviolet

Identifiers

PMID31906275
PMCPMC7017152
OpenAlexW2998548165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.